Obesity and the Dual Diagnosis Child

2012 ◽  
Vol 4 (5) ◽  
pp. 310-314
Author(s):  
Barry M. Panzer ◽  
Sarita Dhuper ◽  
Nitasha Gupta

Many children with excess weight and obesity struggle with comorbid psychiatric disorders and family stressors. These dual diagnosis presentations may be underestimated in epidemiologic surveys and frequently constitute exclusion criteria in childhood obesity treatment studies. As a result, clinical paradigms for this population are lacking and even multispecialty pediatric obesity centers do not provide comprehensive services to these children and their families. Hence, the need for this article, which is a preliminary exploration of possible dynamic mechanisms connecting several psychiatric diagnoses in childhood and excess weight. Based on correlations reported in the literature, depression, oppositional disorder, and attention-deficit/hyperactivity disorder are offered as examples of linear and reciprocal relationships between the two conditions. Notably, eating may be viewed as a means of regulating emotion (depression) and family conflict (oppositionalism) as well as reflecting a lack of regulation (attention-deficit/hyperactivity disorder). This article will hopefully generate subsequent research efforts in this area and enhance practitioner awareness of the complexity of providing effective services to this population.

2021 ◽  
Author(s):  
Kineret Mazor‐Aronovitch ◽  
Orit Pinhas‐Hamiel ◽  
Dikla Pivko‐Levy ◽  
Dalit Modan‐Moses ◽  
Noa Levek ◽  
...  

2020 ◽  
Vol 10 ◽  
pp. 204512532094750
Author(s):  
Louise Öhlund ◽  
Michael Ott ◽  
Robert Lundqvist ◽  
Mikael Sandlund ◽  
Ellinor Salander Renberg ◽  
...  

Background: Currently, our understanding regarding treatment of adult attention deficit hyperactivity disorder (ADHD) co-occurring with bipolar disorder (BD) remains limited. The aim of this study was to evaluate the impact of central stimulant (CS) treatment on suicidal and non-suicidal self-injurious behaviour in patients with a pre-existing diagnosis of BD or schizoaffective disorder (SZD). Specifically, we tested the hypothesis that CS treatment significantly decreased the number of suicide attempts and non-suicidal self-injury events. Methods: A mirror-image study in patients with a dual diagnosis of BD or SZD and ADHD, comparing suicide attempts and non-suicidal self-injury events within 6 months and 2 years before and after CS initiation. This study was part of a retrospective cohort study (LiSIE) into effects and side-effects of lithium for maintenance treatment of BD as compared with other mood stabilisers. Results: Of 1564 eligible patients, 206 patients met the inclusion criteria. Within the 6 months after CS initiation, suicide attempts and non-suicidal self-injury events decreased significantly, both in terms of numbers of patients having such events ( p = 0.013) and numbers of events experienced ( p = 0.004). These effects were preserved 2 years after CS initiation. Conclusions: CS treatment may reduce the risk of suicide attempts and non-suicidal self-injury events in patients with a dual diagnosis of BD or SZD and ADHD. Based on our findings, clinicians should not withhold CS treatment from patients with concomitant ADHD for fear of deterioration of the underlying BD. However, to minimise the risk of manic episodes concomitant mood stabiliser treatment and close monitoring remains warranted.


2004 ◽  
Vol 62 (2b) ◽  
pp. 399-402 ◽  
Author(s):  
Maria Antonia Serra-Pinheiro ◽  
Paulo Mattos ◽  
Isabella Souza ◽  
Giuseppe Pastura ◽  
Fernanda Gomes

OBJECTIVE: To assess the effect of methylphenidate on the diagnosis of oppositional-defiant disorder (ODD) comorbid with attention-deficit hyperactivity disorder (ADHD). METHOD: We conducted an open-label study in which 10 children and adolescents with a dual diagnosis of ODD and ADHD were assessed for their ODD symptoms and treated with methylphenidate. At least one month after ADHD symptoms were under control, ODD symptoms were reevaluated with the Parent form of the Children Interview for Psychiatric Syndromes (P-ChIPS). RESULTS: Nine of the 10 patients no longer fulfilled diagnostic criteria for ODD after they were treated with methylphenidate for ADHD. CONCLUSION: Methylphenidate seems to be an effective treatment for ODD, as well as for ADHD itself. The implications for the treatment of patients with ODD not comorbid with ADHD needs further investigation.


2003 ◽  
Vol 32 (2) ◽  
pp. 241-262 ◽  
Author(s):  
Lisa Marie Angello ◽  
Robert J. Volpe ◽  
James C. DiPerna ◽  
Sammi P. Gureasko-Moore ◽  
David P. Gureasko-Moore ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document